R2PHARMA is a leader in the supply of radiopharmaceuticals for Nuclear Medicine. It operates 8 owned facilities and provides innovative diagnostic and theranostic solutions, serving hundreds of medical services in Brazil and international markets.
| Ownership Private Company |
| Parent Company Grupo RPH |
R2PHARMA is a leading provider of radiopharmaceuticals for nuclear medicine, offering solutions in diagnostics and theranostics and serving over 420 nuclear medicine services in Brazil.
The company provides radiopharmaceuticals for nuclear medicine, serving domestic clinics in Brazil and exporting to over 10 countries.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with R2PHARMA